SterneJACSavovicJPageMJElbersRGBlencoweNSBoutronIet alRob 2: a revised tool for assessing risk of bias in randomised trials
Off-label benefits of GLP-1s are also being evaluated, some of which include improvement in inflammation and arthritis issues, metabolic disorders, addiction disorders (gambling, alcoholism, drugs) and possible benefits for hormone-driven cancers
Neurosci Lett 422:2429 Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011a) Nutritional and metabolic status of children with autism vs
Further in vivo studies using mice demonstrated that, while Cmp2 failed to prominently enhance glucose-mediated insulin release when compared with the more potent peptidic drugs exenatide and liraglutide, it did nevertheless significantly decrease the overall glucose excursion (Irwin et al ., 2010)
When a diverse array of substances is discovered during a search, it can lead to significant confusion for government officials